Company Filing History:
Years Active: 2021-2023
Title: Jason D Roh: Innovator in Cardiac Treatment
Introduction
Jason D Roh is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of cardiac treatment through his innovative patents. With a total of 2 patents, his work focuses on methods for preventing and treating heart disease.
Latest Patents
Roh's latest patents include a method of treating structural and/or functional cardiac abnormalities by administering an anti-ActRII receptor antibody. This patent discloses novel uses and methods for preventing and/or treating heart disease, employing a therapeutically effective amount of an ActRII receptor antagonist, such as the bimagrumab antibody. Another significant patent involves methods for treating and/or reducing the likelihood of heart failure by administering an anti-activin receptor type II (anti-ActRII) antibody. This also relates to innovative approaches for heart disease treatment using the same ActRII receptor antagonist.
Career Highlights
Throughout his career, Jason D Roh has worked with notable organizations, including Novartis AG and Beth Israel Deaconess Medical Center, Inc. His experience in these institutions has contributed to his expertise in cardiac research and treatment methodologies.
Collaborations
Roh has collaborated with esteemed colleagues such as Anthony Rosenzweig and David Jonathan Glass. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Jason D Roh is a key figure in the innovation of cardiac treatments, with a focus on utilizing ActRII receptor antagonists. His contributions through patents and collaborations continue to impact the field of heart disease treatment significantly.